Imaging analysis software company Elucid announced today that it moved its headquarters to Boston’s Back Bay neighborhood. The company moved to a modern space at 399 Boylston Street as it prepares to commercialize its flagship AI-powered plaque analysis software. It previously set up shop about a quarter-mile up the road at 2 Park Plaza in […]
Elucid
Elucid raises $80M Series C for AI-powered imaging analysis software
Elucid announced today that it raised $80 million in a Series C funding round to support its AI-powered imaging analysis software. Boston-based Elucid says the funding could help to expand its commercialization efforts. With a $27 million Series B raised last year, the company has now raised $121 million in total since inception. Elevage Medical […]
Elucid raises $27M for heart disease diagnosis software
Elucid announced that it closed a Series B financing round with proceeds totaling $27 million. Boston-based Elucid’s Series B round was led by an undisclosed strategic investor. A new investor, Biovision Ventures, participated, as did existing investors MedTex Ventures, IAG Capital, Bold Brain Ventures and BlueStone Venture Partners. Elucid designed its FDA-cleared and CE-marked software […]
